UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058974
Receipt number R000067444
Scientific Title Knowledge and Attitudes Towards Cervical Cancer and the Human Papillomavirus Vaccine Among Women in Mukalla City, Yemen: A Cross-Sectional Study
Date of disclosure of the study information 2025/09/25
Last modified on 2025/09/03 06:10:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Knowledge and Attitudes Towards Cervical Cancer and the Human Papillomavirus Vaccine Among Women in Mukalla City, Yemen: A Cross-Sectional Study

Acronym

Knowledge and Attitudes Towards Cervical Cancer and the Human Papillomavirus Vaccine Among Women in Mukalla City, Yemen: A Cross-Sectional Study

Scientific Title

Knowledge and Attitudes Towards Cervical Cancer and the Human Papillomavirus Vaccine Among Women in Mukalla City, Yemen: A Cross-Sectional Study

Scientific Title:Acronym

Knowledge and Attitudes Towards Cervical Cancer and the Human Papillomavirus Vaccine Among Women in Mukalla City, Yemen: A Cross-Sectional Study

Region

Asia(except Japan)


Condition

Condition

Retrospective Study

Classification by specialty

Infectious disease Obstetrics and Gynecology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to assess the level of knowledge and attitudes regarding cervical cancer and the human papillomavirus (HPV) vaccine among women residing in Mukalla City, Yemen. The study aims to identify gaps in awareness and misconceptions that may impact the acceptance and uptake of cervical cancer prevention measures. Understanding these factors will help inform targeted public health interventions to improve cervical cancer screening and HPV vaccination coverage in this population.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome was to assess the level of knowledge and attitudes towards cervical cancer and the human papillomavirus (HPV) vaccine among women in Mukalla City, Yemen.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Female

Key inclusion criteria

Inclusion Criteria
Women aged 18 years and above.

Residents of Mukalla City, Yemen.

Women capable of providing informed consent to participate.

Women with no prior diagnosis or treatment for cervical cancer.

Key exclusion criteria

Exclusion Criteria
Pregnant women.

Women with a history of cervical cancer or precancerous cervical lesions.

Women currently undergoing treatment for any gynecological cancer.

Women with cognitive impairments or conditions limiting their ability to participate or respond to survey questions.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Ahmed
Middle name
Last name Badheeb

Organization

Hadhramout University College of Medicine, Hadhramout, Yemen.

Division name

Department of Oncology

Zip code

NA

Address

Oncology Centre, King Khalid Hospital Alkhalidiyyah, King Abdulaziz Road P.O. Bo

TEL

00966-538318439

Email

badheebdr@gmail.com


Public contact

Name of contact person

1st name Ahmed
Middle name Mohammed
Last name Badheeb

Organization

Ibb University

Division name

Department of Surgery

Zip code

NA

Address

Oncology Centre, King Khalid Hospital Alkhalidiyyah, King Abdulaziz Road P.O. Bo

TEL

00966-538318439

Homepage URL


Email

badheebdr@gmail.com


Sponsor or person

Institute

General Surgery Department, King Khalid Hospital, Najran, Saudi Arabia

Institute

Department

Personal name



Funding Source

Organization

General Surgery Department, King Khalid Hospital, Najran, Saudi Arabia

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ibb University

Address

Al-Thora General Hospital, Department of Urology, School of Medicine, Ibb University of Medical Sciences, Ibb, Yemen.

Tel

009674416416

Email

fmaaa2006@yahoo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

425

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 05 Month 13 Day

Date of IRB

2024 Year 09 Month 17 Day

Anticipated trial start date

2022 Year 10 Month 13 Day

Last follow-up date

2025 Year 06 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A cross-sectional study was conducted from June to August 2023 among 425 women aged 18 years and older in Mukalla City, Yemen. Participants were recruited via convenience sampling from primary healthcare centers and three major malls. Pregnant women and those with a history of cervical cancer were excluded. Data were collected using an interviewer-administered, pre-tested questionnaire assessing sociodemographics, knowledge, and attitudes towards cervical cancer and HPV vaccination. Trained healthcare personnel ensured uniform data collection. Descriptive statistics and multivariate logistic regression were used to analyze associations between sociodemographic factors and knowledge or attitudes. SPSS version 26 was utilized for data analysis.


Management information

Registered date

2025 Year 09 Month 03 Day

Last modified on

2025 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067444